Avego Healthcare Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Avego Healthcare Capital has invested in 4 companies.

Avego Healthcare Capital’s most common sectors for investment arelife science (86%) and consumer services (15%) . The Firm’s most common investment types include venture (43%) and growth capital (29%). In total, Avego Healthcare Capital has invested in 5 US states.

In the last 3 years, Avego Healthcare Capital has exited 1 company. The Firm’s most common exit type is trade sale (100%).

Join Mergr to view Avego Healthcare Capital’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity7
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Avego Healthcare Capital

1055B Powers Place,
Alpharetta, Georgia 30009
United States
www.avego.com


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Life Science, Medical Products, Packaging

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (1.0/yr) # 2 1 - - 4 - 7
Sell (0.2/yr) # - - - 1 - - 1
  8

Most Recent M&A

Company Date Value Type
Ellie Diagnostics LLC 2021-11-10 - Growth Capital
Richardson, Texas · www.elliediagnostics.com
Antios Therapeutics, Inc. 2021-11-03 - Venture
Atlanta, Georgia · www.antiostherapeutics.com
Ribon Therapeutics, Inc. 2021-07-14 - Venture
Cambridge, Massachusetts · www.ribontx.com
Arch Oncology 2021-04-27 - Venture
Brisbane, California · www.archoncology.com
Eyevance Pharmaceuticals 2020-09-16 - Add-on Acquisition
Fort Worth, Texas · www.eyevance.com
Meridien Research Corporate 2018-04-16 - Secondary Buyout
Winter Park, Florida · www.meridienresearch.net
Saol Therapeutics 2017-01-02 - Buyout (LBO, MBO, MBI)
Roswell, Georgia · www.saolrx.com
Sebela Pharmaceuticals, Inc. 2013-08-26 - Growth Capital
Roswell, Georgia · www.sebelapharma.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Saol Therapeutics 2017-01-02 Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 1
Roswell, Georgia · www.saolrx.com Seattle, Washington

M&A by Sector

Sector Current # Value All-time # Value
Life Science 6 (86%) - 6 (86%) -
Consumer Services 1 (14%) - 1 (14%) -
Total 7 - 7 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (100%) - 7 (100%) -
  Georgia 3 (43%) - 3 (43%) -
  Texas 1 (14%) - 1 (14%) -
  Massachusetts 1 (14%) - 1 (14%) -
  Florida 1 (14%) - 1 (14%) -
  California 1 (14%) - 1 (14%) -
Total 7 - 7 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 3 (43%) - 3 (43%) -
Growth Capital 2 (29%) - 2 (29%) -
Buyout (LBO, MBO, MBI) 1 (14%) - 1 (14%) -
Secondary Buyout 1 (14%) - 1 (14%) -
Total 7 - 7 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 1 (100%) -
Total 1 -

M&A Connections

Deals
Acquired from
Investor(s)
14%
1 (14%)
Exited to
Strategic(s)
100%
1 (100%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2015

Specialist/Generalist

Specialist

Leadership

Bala Venkataraman

Partner

James Flexner

Partner

Thomas Vandervort

Partner

Kevin McNeill

Principal

Jordan McLean

Vice President

 Subscribe to unlock this and 182,879
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 173K M&A Transactions
  • 179K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 65K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal